An observational study in Eating Disorders, Anorexia Nervosa and Boulimia Nervosa, sponsored by Centre Hospitalier Esquirol. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Centre Hospitalier Esquirol · Observational
This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.
The study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.
469 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.
This study's planned enrollment of 150 is above the median of 78 across 142 observational studies indexed under Anorexia Nervosa.
Browse Anorexia Nervosa studies →Centre Hospitalier Esquirol is the lead sponsor of 25 studies on the registry; 7 are open to participants now.
Compared within Anorexia Nervosa, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Feeding and Eating Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Participants will be enrolled during hospitalization or consultation of their Eating Disorder treatment in the Esquirol Hospital Center of Limoges, France.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Five questionnaires were administered at inclusion, socio-demographic and clinical data were collected during an interview (anxiety-depression, treatments). The following questionnaires were used: The Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Eating Disorder Examination Self-Report Questionnaire (EDE-Q), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS), the Hospital anxiety and depression scale (HAD) and the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2).
Sensory profile from the Adolescent and Adult Sensory Profile (Brown and Dunn, 2002) according to each diagnostic group.
Sensory profile scores will be obtained using the Adolescent and Adult Sensory Profile (AASP) scale during an individual interview after the participant has been included in the study. Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance will be collected. For each subscore, the minimum and maximum values range from 15 to 75. A high score indicates high sensory sensitivity.
Time frame: At enrollment
Scores for task coping drawn from the Coping Inventory for Stressful Situations (Endler & Parker, adapted by JP Rolland) according to each diagnostic group
Coping scores will be obtained using the Coping Inventory for Stressful Situations (CISS) scale during an individual interview after the participant has been included in the study. The task-oriented coping subscore, emotion subscore, avoidance subscore, distraction subscore, and social diversion subscore will be collected. The minimum and maximum values range from 16 to 90. A high score indicates high oriented coping.
Time frame: at enrollment
Description of the frequency of autistic traits for each diagnostic group
The frequency of autistic traits will be obtained using the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr) during an individual interview after the participant has been included in the study. The minimum and maximum values range from 0 to 240. The generally accepted threshold for significant autistic traits is 70. A high score indicate high autistic traits.
Time frame: At enrollment
Description of the frequency of eating disorders for each diagnostic group.
Eating disorders will be assessed using the Eating Disorder Examination Self-Report Questionnaire (EDE-Q) during an individual interview after the participant's inclusion. The EDE-Q, provide subscale scores reflecting the severity of aspects of the psychopathology of eating disorders. The subscales are Restraint, Eating Concern, Shape Concern and Weight Concern. For Restaint subscale minimum and maximum values range from 0 to 30. For Eating Concern subscale minimum and maximum values range from 0 to 30. For Shape Concern subscale minimum and maximum values range from 0 to 48. For Weight Concern subscale minimum and maximum values range from 0 to 30. The higher the score, the more severe the symptoms.
Time frame: At enrollment
Anxiety according to each diagnostic group.
Anxiety and depression will be obtained using the Hospital Anxiety and Depression Scale (HAD) during an individual interview after the participant's inclusion. The anxiety subscore will be collected. Minimum and maximum values range from 0 to 21. The generally accepted threshold for significant anxiety is 11.
Time frame: At enrollment
Body awareness from the multidimensional assessment of interoceptive awareness for each diagnostic group.
Body awareness will be obtained using the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2) scale during an individual interview after the participant's inclusion. Minimum and maximum values range from 0 to 185. A high score indicates high interoceptive awareness.
Time frame: At enrollment
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Esquirol